CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 136 enrolled
Drug / intervention
STEPP Interventionbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06010017
NCT06010017N/ACompleted
CompareCT.gov

Peer Support Intervention for Patients Undergoing Hematopoietic Stem Cell Transplantation (STEPP): Feasibility and Preliminary Efficacy Trial

Brigham and Women's Hospital·interventional·Posted Aug 24, 2023·Updated Aug 5, 2025

In Brief

A clinical study evaluating STEPP Intervention for Hematopoietic Neoplasms and Hematopoietic Malignancy. Completed, enrolled 136 participants across 2 sites.

Detailed Summary

The main purpose of this study is to determine if a novel peer support intervention (STEPP) is feasible among patients undergoing hematopoietic stem cell transplantation (HSCT). The name of the intervention used in this research study is STEPP, a peer support intervention comprised of five learning modules on psychoeducation and supportive psychotherapy strategies, tailored to the unique needs of patients undergoing HSCT.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHematopoietic Neoplasms, Hematopoietic Malignancy
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedAug 24, 2023
Enrollment StartFeb 20, 2024
Primary CompletionMar 3, 2025
Study CompletionMar 21, 2025
TodayJul 2, 2026
Enrollment to primary: 1.0 yearsPosted 2.9 years ago

Interventions

STEPP Interventionbehavioral

Peer support intervention comprised of five learning modules on psychoeducation and supportive psychotherapy strategies, via virtual platform. If participants do not have a smart device, one will be provided by the study team.